Decrease in blood pressure (hypotension). It increases blood pressure by constricting the blood vessels, it triggers thirst and the desire for salt. Increased levels of angiotensin can result in excess fluid being retained by the body.
The ACE inhibitors lowers blood pressure by preventing the production of Angiotensin II, while Angiotensin receptor blockers reduce the action of angiotensin II to prevent blood vessel constriction.
It helps to relax the veins and arteries to lower blood pressure and it prevents an enzyme in the body from producing angiotensin II which is a substance that narrows blood vessels.
They bind the AT1 receptor found in vascular smooth muscle and adrenal gland.
Kinins induce vasodilation, Increasing blood flow throughout the body and a brief fall in blood pressure.
Bradykinin displays the highest affinity for B2 ( bradykinin 2 Receptors)
Natriuretic Peptides may be administered as recombinant ANP, recombinant BNP or ularitide. They produce vasodilation and natriuresis and have been investigated for the treatment of congestive heart failure. Natriuretic Peptides causes vasodilation and this helps to dilate the arteries (increase in blood flow) and this leads to a fall in blood pressure and this is effective in the treatment of hypertension.
Neprilysin is a zinc-dependent metalloprotease and it blocks Ang II receptors. It is used to treat high blood pressure and heart failure. By blocking its action it prevents the breakdown of natriuretic peptides. Drugs are omapatrilat, sampatrilat and fasidotrilat.
endothelium-derived vasodilator/ endothelium-derived relaxing factor- Nitric oxide: plays a role in endothelial functions.
endothelium-derived vasoconstrictors/ endothelium-derived contracting factors- Endothelin-1 and Cox-derived thromboxane.